Myofascial Release and 20-m Speed in Wheelchair Rugby Athletes With Spinal Cord Injury (NCT07711015) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Myofascial Release and 20-m Speed in Wheelchair Rugby Athletes With Spinal Cord Injury
Brazil12 participantsStarted 2026-08-17
Plain-language summary
This study aims to investigate the effect of myofascial release on sprint performance in wheelchair rugby athletes with spinal cord injury.
Participants will complete a 20-meter sprint test on two different days in a randomized crossover design: one day without myofascial release and one day immediately after the intervention.
The myofascial release will be applied to the upper limb muscles involved in wheelchair propulsion using a handheld device for 90 seconds per muscle group.
Sprint performance will be measured by the time required to complete the 20-meter distance.
The study will compare performance between conditions to determine whether myofascial release improves speed.
Who can participate
Age range
18 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Men and women
* Aged 18 years or older
* Cervical spinal cord injury (tetraplegia)
* Practice of wheelchair rugby for at leastm12 months
* Participating in team training sessions for at least 3 months prior to the study.
Exclusion Criteria:
* Musculoskeletal pain
* Injury that prevents completion of the study protocol.
* Wounds, pressure ulcers, or skin lesions at the site of myofascial release application
* Recreational athletes
* Medical contraindication to manual therapy
* Infection, fever, or acute illness at the time of assessment
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Sprint Time (20 meters wheelchair test)
Timeframe: Immediately after each experimental condition (with and without myofascial release), during the 20-meter sprint test sessions.